IMI impact on dementia virtual event – one week left to register!
The Innovative Medicines Initiative (IMI) is organising a series of online live sessions on IMI’s
Sin categoría
MIMETAS opens new Phenotypic Screening Center in Leiden
PD-MitoQUANT partner MIMETAS, the global leader in human-relevant organ-on-a-chip models, opened their new Phenotypic Screening
IDEA-FAST is pleased to welcome LUPUS UK on board of the project!
One of the ways in which the IDEA-FAST project ensures that the patient voice is
Neuronet ECR submission for the virtual Alzheimer Europe Conference is open!
Neuronet invites Early Career Researchers from the Innovative Medicines Initiative’s neurodegeneration research projects to present
1st Fraunhofer Symposium on the “Human Brain PHARMACOME”
The neurodegeneration research community remembers the major outcome of the AETIONOMY project funded by the
Communication representatives of neurodegeneration research projects exchange on best practices
On 7 May, representatives of 12 Innovative Medicines Initiative neurodegeneration research projects met virtually to
Explore the AD Workbench to access the European Prevention of Alzheimer’s Dementia study data
As previously announced, the latest and final EPAD dataset called Version.IMI (V.IMI) is now available
Parkinson’s Research in Ireland event series 2.0 was a huge success & video recordings are now online!
The “Parkinson’s Research in Ireland” seminar series 2.0 took place on April 8th and 15th,
RADAR-AD project members gather online for the second annual consortium meeting to discuss progress and future plans
The annual RADAR-AD meeting provides consortium members from various work streams with the opportunity to
EMIF study shows that plasma biomarkers can predict the presence of Alzheimer’s disease pathology in the brain
When it comes to brain pathology, Alzheimer’s disease (AD) is defined by loss and gain: